Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katzelnick

Showing results (121-130 of 144) with videos related to

Pageof 15
Sort By:
Science Translational Medicine|April 24, 2024
Antigenic distance between primary and secondary dengue infections correlates with disease riskLin Wang, Angkana T Huang, Leah C Katzelnick, et al.
Nature Communications|September 18, 2020
A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severityAngkana T Huang, Bernardo Garcia-Carreras, Matt D T Hitchings, et al.
Nature Communications|January 3, 2025
Dengue virus IgG and neutralizing antibody titers measured with standard and mature viruses are protectiveCamila D Odio, Jedas Veronica Daag, Maria Vinna Crisostomo, et al.
Science (New York, N.Y.)|June 23, 2012
The potential for respiratory droplet-transmissible A/H5N1 influenza virus to evolve in a mammalian hostColin A Russell, Judith M Fonville, André E X Brown, et al.
The Lancet. Infectious Diseases|March 2, 2025
Zika virus vaccines and monoclonal antibodies: a priority agenda for research and developmentJulia T Ostrowsky, Leah C Katzelnick, Nigel Bourne, et al.
Medrxiv : the Preprint Server for Health Sciences|August 3, 2021
Epidemics of chikungunya, Zika, and COVID-19 reveal bias in case-based mappingFausto Andres Bustos Carrillo, Brenda Lopez Mercado, Jairo Carey Monterrey, et al.
Science Translational Medicine|October 6, 2021
Dengue and Zika virus infections in children elicit cross-reactive protective and enhancing antibodies that persist long termLeah C Katzelnick, Jose Victor Zambrana, Douglas Elizondo, et al.
Science (New York, N.Y.)|August 29, 2020
Zika virus infection enhances future risk of severe dengue diseaseLeah C Katzelnick, César Narvaez, Sonia Arguello, et al.
Journal of Clinical Psychopharmacology|April 19, 2014
Treatment outcomes of depression: the pharmacogenomic research network antidepressant medication pharmacogenomic studyDavid A Mrazek, Joanna M Biernacka, Donald E McAlpine, et al.
Frontiers in Immunology|August 9, 2021
Adapting Rapid Diagnostic Tests to Detect Historical Dengue Virus InfectionsFernando Echegaray, Peter Laing, Samantha Hernandez, et al.
Pageof 15

Showing results (121-130 of 144) with videos related to

Sort By:
Pageof 15
Science Translational Medicine|April 24, 2024
Antigenic distance between primary and secondary dengue infections correlates with disease riskLin Wang, Angkana T Huang, Leah C Katzelnick, et al.
Nature Communications|September 18, 2020
A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severityAngkana T Huang, Bernardo Garcia-Carreras, Matt D T Hitchings, et al.
Nature Communications|January 3, 2025
Dengue virus IgG and neutralizing antibody titers measured with standard and mature viruses are protectiveCamila D Odio, Jedas Veronica Daag, Maria Vinna Crisostomo, et al.
Science (New York, N.Y.)|June 23, 2012
The potential for respiratory droplet-transmissible A/H5N1 influenza virus to evolve in a mammalian hostColin A Russell, Judith M Fonville, André E X Brown, et al.
The Lancet. Infectious Diseases|March 2, 2025
Zika virus vaccines and monoclonal antibodies: a priority agenda for research and developmentJulia T Ostrowsky, Leah C Katzelnick, Nigel Bourne, et al.
Medrxiv : the Preprint Server for Health Sciences|August 3, 2021
Epidemics of chikungunya, Zika, and COVID-19 reveal bias in case-based mappingFausto Andres Bustos Carrillo, Brenda Lopez Mercado, Jairo Carey Monterrey, et al.
Science Translational Medicine|October 6, 2021
Dengue and Zika virus infections in children elicit cross-reactive protective and enhancing antibodies that persist long termLeah C Katzelnick, Jose Victor Zambrana, Douglas Elizondo, et al.
Science (New York, N.Y.)|August 29, 2020
Zika virus infection enhances future risk of severe dengue diseaseLeah C Katzelnick, César Narvaez, Sonia Arguello, et al.
Journal of Clinical Psychopharmacology|April 19, 2014
Treatment outcomes of depression: the pharmacogenomic research network antidepressant medication pharmacogenomic studyDavid A Mrazek, Joanna M Biernacka, Donald E McAlpine, et al.
Frontiers in Immunology|August 9, 2021
Adapting Rapid Diagnostic Tests to Detect Historical Dengue Virus InfectionsFernando Echegaray, Peter Laing, Samantha Hernandez, et al.
Pageof 15